Compare Moderna, Inc. (MRNA) vs Materials Select Sector SPDR Fund (XLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Materials Select Sector SPDR Fund — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Materials Select Sector SPDR Fund trades at $50.01. Which is the better fit depends on your goals.
| MRNA | XLB | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | — |
52-Week High | $81.80 | $53.62 |
52-Week Low | $22.36 | $42.23 |
Enterprise Value | $19.70B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Materials Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: chemicals; metals and mining; paper and forest products; containers and packaging; and construction materials. The fund is non-diversified.
Read more on XLB →
